The Magazine for Sleep Professionals
Friday, April 24, 2026
Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Efficacy […]
Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]
Statement of American Lung Association National President and CEO Harold P. Wimmer in response to the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report “Tobacco Product Use Among Middle and High School Students—United States, 2011–2017,” released on June 6, 2018. “For the fourth straight year, the […]
Tobacco is the leading underlying single cause of death worldwide. In 2016, tobacco use caused over 7.1 million deaths mostly related to lung and heart disease, cancer, and stroke. Every year, on May 31, people and organizations mark World No Tobacco Day, by highlighting the health and other risks associated with […]
NARCOLEPSY EDUCATION DAY PLEASE JOIN US FOR A DAY OF INFORMATION ON NARCOLEPSY AND CONNECTION WITH OTHERS WHOSE LIVES ARE AFFECTED BY NARCOLEPSY When? 9am-3pm SEPTEMBER 22, 2018 Where? AT THE DOUBLETREE HILTON HOTEL TARRYTOWN, NY FOR MORE INFORMATION OR TO REGISTER CONTACT TAMMY SMITH AT tsmith@wakeupnarcolepsy.org WAKE UP NARCOLEPSY IS […]
Researchers analyzed prevalence studies from 16 countries, together with data from the World Health Organization and United Nations World Population Prospects A new data analysis presented by ResMed this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide […]
All in for CF Scholarship Program Doubles to Help 80 Recipients Pursue Higher Education Vertex Pharmaceuticals Incorporated announced the recipients of scholarships as part of its second All in for CF Scholarship program. Each of the 80 scholarship recipients will be awarded $5,000 for the 2018-2019 academic year. The Vertex […]
Electromed, Inc. recently announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique. The longitudinal study shows that high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related exacerbations including the need for antibiotics, emergency department visits, and […]
You may already know the clinical benefits of home NIV, but now discover the significant cost savings this new approach could bring to your organization. Emerging evidence has reinforced the use of home-based noninvasive ventilation (NIV) to treat patients with chronic hypercapnic COPD. This new methodology was proven in the […]
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD GlaxoSmithKline plc and Innoviva, Inc. today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’), which means Trelegy Ellipta can now be used […]
